Organicell Regenerative Medicine, Inc. Reports annual revenue of $4.6 million

Organicell Regenerative Medicine, Inc. [OCEL] has reported $4.6 million in revenue for year ended Oct 31, 2023. 

Also Read: One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID  

The company said in a filing before the Securities and Exchange Commission that its loss for the year was $7.0 million. 

Also Read: Chronic Obstructive Pulmonary Disease (COPD) Market Expected to Reach $25 Billion By 2027